Rezolute (RZLT) Enterprise Value (2010 - 2026)
Rezolute (RZLT) reported Enterprise Value of -$120.2 million for Q1 2026, down 38.36% on a YoY basis from -$195.0 million in Q1 2025, and up 9.56% sequentially from -$132.9 million in Q4 2025.
Rezolute (RZLT) Enterprise Value (2010 - 2026) Analysis & Trends
Rezolute (RZLT) has 13 years of Enterprise Value data on file, last reported at -$120.2 million in Q1 2026.
- For the quarter ending Q1 2026, Enterprise Value fell 38.36% year-over-year to -$120.2 million; the trailing twelve-month figure through Mar 2026 stood at -$120.2 million (down 38.36% YoY), and the FY2025 full-year result was -$167.9 million, down 32.3% from the prior year.
- Enterprise Value rose to -$120.2 million in Q1 2026, from -$132.9 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$63.4 million in Q1 2022 to a low of -$167.9 million in Q2 2025.
- A 5-year average of -$116.7 million and a median of -$108.3 million in 2024 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value tumbled 313.82% in 2022 and jumped 36.9% in 2023, its largest moves.
- Tracing RZLT's Enterprise Value over 5 years: stood at -$146.7 million in 2022, then jumped by 36.9% to -$92.6 million in 2023, then decreased by 4.25% to -$96.5 million in 2024, then sank by 37.71% to -$132.9 million in 2025, then increased by 9.56% to -$120.2 million in 2026.
- Business Quant data shows RZLT's Enterprise Value at -$120.2 million in Q1 2026, -$132.9 million in Q4 2025, and -$152.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Rezolute | 31,153.77 | 31,153.77 | - | -120.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.23 Mn |
| Dec 31, 2025 | -132.94 Mn |
| Sep 30, 2025 | -152.20 Mn |
| Jun 30, 2025 | -167.86 Mn |
| Mar 31, 2025 | -86.90 Mn |
| Dec 31, 2024 | -96.54 Mn |
| Sep 30, 2024 | -108.27 Mn |
| Jun 30, 2024 | -126.87 Mn |
| Mar 31, 2024 | -80.02 Mn |
| Dec 31, 2023 | -92.60 Mn |
| Sep 30, 2023 | -98.80 Mn |
| Jun 30, 2023 | -101.90 Mn |
| Mar 31, 2023 | -103.02 Mn |
| Dec 31, 2022 | -146.75 Mn |
| Sep 30, 2022 | -154.32 Mn |
| Jun 30, 2022 | -150.41 Mn |
| Mar 31, 2022 | -63.42 Mn |
| Dec 31, 2021 | -77.40 Mn |
| Sep 30, 2021 | -37.29 Mn |
| Jun 30, 2021 | -41.05 Mn |